Evofem Biosciences Financials

Evofem Biosciences Stock Summary

Evofem Biosciences competes with Tonix Pharmaceuticals, Sonnet Biotherapeutics, Palisade Bio, Ibio, and Bright Minds. Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in womens sexual and reproductive health. Evofem Biosciences, Inc. is headquartered in San Diego, California. Evofem Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 119 people.

Evofem Biosciences Key Financial Ratios

There are many critical financial ratios that Evofem Biosciences' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Evofem Biosciences reports annually and quarterly.

Evofem Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Evofem Biosciences's current stock value. Our valuation model uses many indicators to compare Evofem Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Evofem Biosciences competition to find correlations between indicators driving Evofem Biosciences's intrinsic value. More Info.Evofem Biosciences is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Evofem Biosciences' earnings, one of the primary drivers of an investment's value.

Evofem Biosciences Market Pulse

Along with financial statement analysis, the daily predictive indicators of Evofem Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Evofem Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Evofem Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Evofem OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Evofem Biosciences's daily price indicators and compare them against related drivers.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in census. Note that the Evofem Biosciences information on this page should be used as a complementary analysis to other Evofem Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

If you are still planning to invest in Evofem Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evofem Biosciences' history and understand the potential risks before investing.